PMID- 31048676 OWN - NLM STAT- MEDLINE DCOM- 20190506 LR - 20220410 IS - 1545-861X (Electronic) IS - 0149-2195 (Print) IS - 0149-2195 (Linking) VI - 68 IP - 17 DP - 2019 May 3 TI - Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017. PG - 388-395 LID - 10.15585/mmwr.mm6817a3 [doi] AB - In 2016, a total of 63,632 persons died from drug overdoses in the United States (1). Drug overdose deaths involving cocaine, psychostimulants with abuse potential (psychostimulants), or both substances combined increased 42.4% from 12,122 in 2015 to 17,258 in 2016.* Psychostimulants with abuse potential include drugs such as methamphetamine, 3,4-methylenedioxy-methamphetamine (MDMA), dextroamphetamine, levoamphetamine, methylphenidate (Ritalin), and caffeine. From 2015 to 2016, cocaine-involved and psychostimulant-involved death rates increased 52.4% and 33.3%, respectively (1). A total of 70,237 persons died from drug overdoses in the United States in 2017; approximately two thirds of these deaths involved an opioid (2). CDC analyzed 2016-2017 changes in age-adjusted death rates involving cocaine and psychostimulants by demographic characteristics, urbanization levels, U.S. Census region, 34 states, and the District of Columbia (DC). CDC also examined trends in age-adjusted cocaine-involved and psychostimulant-involved death rates from 2003 to 2017 overall, as well as with and without co-involvement of opioids. Among all 2017 drug overdose deaths, 13,942 (19.8%) involved cocaine, and 10,333 (14.7%) involved psychostimulants. Death rates increased from 2016 to 2017 for both drug categories across demographic characteristics, urbanization levels, Census regions, and states. In 2017, opioids were involved in 72.7% and 50.4% of cocaine-involved and psychostimulant-involved overdoses, respectively, and the data suggest that increases in cocaine-involved overdose deaths from 2012 to 2017 were driven primarily by synthetic opioids. Conversely, increases in psychostimulant-involved deaths from 2010 to 2017 occurred largely independent of opioids, with increased co-involvement of synthetic opioids in recent years. Provisional data from 2018 indicate that deaths involving cocaine and psychostimulants are continuing to increase.(dagger) Increases in stimulant-involved deaths are part of a growing polysubstance landscape. Increased surveillance and evidence-based multisectoral prevention and response strategies are needed to address deaths involving cocaine and psychostimulants and opioids. Enhancing linkage to care, building state and local capacity, and public health/public safety collaborations are critical components of prevention efforts. FAU - Kariisa, Mbabazi AU - Kariisa M AD - Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. FAU - Scholl, Lawrence AU - Scholl L AD - Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. FAU - Wilson, Nana AU - Wilson N AD - Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. FAU - Seth, Puja AU - Seth P AD - Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. FAU - Hoots, Brooke AU - Hoots B AD - Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. LA - eng PT - Journal Article DEP - 20190503 PL - United States TA - MMWR Morb Mortal Wkly Rep JT - MMWR. Morbidity and mortality weekly report JID - 7802429 RN - 0 (Analgesics, Opioid) RN - 0 (Central Nervous System Stimulants) RN - I5Y540LHVR (Cocaine) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Analgesics, Opioid/*poisoning MH - Central Nervous System Stimulants/*poisoning MH - Cocaine/*poisoning MH - Drug Overdose/ethnology/*mortality MH - Female MH - Humans MH - Male MH - Middle Aged MH - Racial Groups/statistics & numerical data MH - United States/epidemiology MH - Urbanization MH - Young Adult PMC - PMC6541315 COIS- All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed. EDAT- 2019/05/03 06:00 MHDA- 2019/05/07 06:00 PMCR- 2019/05/03 CRDT- 2019/05/04 06:00 PHST- 2019/05/04 06:00 [entrez] PHST- 2019/05/03 06:00 [pubmed] PHST- 2019/05/07 06:00 [medline] PHST- 2019/05/03 00:00 [pmc-release] AID - mm6817a3 [pii] AID - 10.15585/mmwr.mm6817a3 [doi] PST - epublish SO - MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):388-395. doi: 10.15585/mmwr.mm6817a3.